메뉴 건너뛰기




Volumn 9, Issue 10, 2003, Pages 811-818

Leptin: From animals to humans

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE; CYCLIC AMP; DNA; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; JANUS KINASE; MELANOCORTIN; MESSENGER RNA; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; RECOMBINANT LEPTIN; STAT1 PROTEIN; STAT3 PROTEIN; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

EID: 0037244307     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033455369     Document Type: Review
Times cited : (42)

References (96)
  • 15
    • 0029048408 scopus 로고
    • (5223) Comment in: Science, 1995, 269(5223) 475
    • Campfield, L.A., Smith, F.J., Guisez, Y., Science, 1995, 269(5223) 546, Comment in: Science, 1995, 269(5223) 475.
    • (1995) Science , vol.269 , pp. 546
    • Campfield, L.A.1    Smith, F.J.2    Guisez, Y.3
  • 73
  • 94
    • 0035031036 scopus 로고    scopus 로고
    • Leptin transport across the blood-brain barrier: Implications for the cause and treatment of obesity
    • Banks, W. A. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr. Pharm. Des. 2001, 7(2), 125-33.
    • (2001) Curr. Pharm. Des. , vol.7 , Issue.2 , pp. 125-133
    • Banks, W.A.1
  • 95
    • 0035031042 scopus 로고    scopus 로고
    • Current therapies and emerging targets for the treatment of diabetes
    • Wagman, A. S.; Nuss, J. M. Current therapies and emerging targets for the treatment of diabetes. Curr. Pharm. Des. 2001, 7(6), 417-50.
    • (2001) Curr. Pharm. Des. , vol.7 , Issue.6 , pp. 417-450
    • Wagman, A.S.1    Nuss, J.M.2
  • 96
    • 0034850444 scopus 로고    scopus 로고
    • Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: A physiological approach toward improved metabolic control
    • Weyer, C.; Maggs, D. G.; Young, A. A.; Kolterman, O. G. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr. Pharm. Des. 2001, 7(14), 1353-73.
    • (2001) Curr. Pharm. Des. , vol.7 , Issue.14 , pp. 1353-1373
    • Weyer, C.1    Maggs, D.G.2    Young, A.A.3    Kolterman, O.G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.